Skip to main content
Radcliffe Medical Education
Medical education learning resources for healthcare professionals
Radcliffe Medical Education banner
Radcliffe Medical Education banner
  • Home
  •  Imaging vs Angiography-Led PCI: What Does Success Look Like?

Imaging vs Angiography-Led PCI: What Does Success Look Like?

Topic:
  • Prevention

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

Imaging vs Angiography-Led PCI: What Does Success Look Like?
No ratings

Overview

In this session, ‘Imaging vs angiography-led PCI: What does success look like?’ part of the ‘Optimising the Use of Contemporary Invasive Imaging for PCI’ series a leading faculty discuss the use of imaging and angiography for procedural planning and PCI optimisation. Through the use of cases, faculty will explore how imaging has been used to maximise successful stent implantation.

 

‘Optimising the Use of Contemporary Invasive Imaging for PCI aims to offer education on proper image acquisition, interpretation, and correct decision-making to optimise the use of contemporary imaging. The programme provides an overview of the current use of intravascular ultrasound (IVUS) and optical coherence tomography (OCT), the relative advantages of each technique and real-world insight from imaging experts. 

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.


The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session of ‘Imaging vs angiography-led PCI: What does success look like?' is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Support Statement

This programme is supported by an unrestricted educational grant by Abbott. The scientific programme has not been influenced in any way by the sponsors.

Instruction to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.

 

  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

  • Cardiologists
  • Interventionalists
  • Physicians within the peripheral intervention space
  • Imaging specialists

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Incorporate contemporary imaging for PCI in appropriate patients
  • Differentiate between modern imaging techniques based on clinical data
  • Recall best practices for image acquisition, interpretation and decision-making
  • Interpret image data and make clinical decisions generated from existing case study data

Chair

Evan Shlofmitz

St. Francis Hospital & Heart Center, New York, US

Dr Evan Shlofmitz is an Interventional Cardiologist at St. Francis Hospital & Heart Center, New York, US. He is also Executive Director of Optimizing PCI (OPCI).

View full profile

Speaker

Nieves Gonzalo

Hospital Clinico San Carlos, Madrid, Spain

Dr Nieves Gonzalo is Consultant Interventional Cardiologist at the Interventional Cardiology Department at Clinico San Carlos University Hospital in Madrid.

View full profile

Speaker

Jonathan Hill

Royal Brompton Hospital, London, UK

Dr Jonathan Hill qualified from Edinburgh University Medical School in 1992 following pre-clinical training at Cambridge University. He trained in cardiology at The London Chest and St Bartholomew's Hospitals. 

View full profile
1.00 EBAC

Related Courses

Severe Hypertriglyceridaemia: Defining the Disease and Its Management
  • 1.00 EBAC

Learning objectives

  • Recall the mechanisms that make TGs a risk factor for atherosclerosis
  • Review how elevated FCS is a major risk factor for pancreatitis
  • Discuss the current clinical evidence of TG-lowering therapies in different disease states
See more
Targeting Residual Inflammatory Risk: The Future of Cardiovascular Prevention
  • 1.00 EBAC

Learning objectives

  • Define residual inflammatory risk (RIR) and explain why cardiovascular events continue to occur in patients despite optimal lipid-lowering and antihypertensive therapies
  • Describe the pathophysiological role of inflammation in atherosclerosis, myocardial infarction, heart failure and chronic kidney disease
  • Identify patients at increased cardiovascular risk due to elevated inflammatory markers, particularly high-sensitivity C-reactive protein (hsCRP)
  • Interpret the clinical significance of hsCRP and other inflammatory biomarkers in primary and secondary prevention settings, in alignment with current evidence and guideline recommendations
  • Assess clinician practices, barriers and strategies for integrating inflammatory risk assessment and management
  • Apply key takeaways to inform future risk assessment and treatment decisions in patients with or at risk for cardiovascular disease
See more
Revolutionising Thrombosis Treatment in ACS, SSP and AF
  • 1.00 EBAC

Learning objectives

  • Discuss the unmet needs in thrombosis management, MACE burden after ACS, stroke in AF and secondary stroke prevalence and consequences
  • Evaluate the current standard of care for the treatment of ACS, SSP and AF and its limitations
  • Review guidelines and critique current prescribing practices and the implications of inadequate treatment
  • Explain the different strategies for targeting FXI and how FXI inhibition mechanisms differentiate from traditional anticoagulation therapies
  • Identify emerging anticoagulant strategies and describe the efficacy and safety data from Phase 2 FXI inhibitor clinical trials as well as ongoing Phase 3 trials and potential place in therapy for ACS, AF and SSP
  • Apply evidence-based anticoagulation strategies by optimising treatment decisions and addressing patient-specific risk factors
See more
The Rise of CVRM Medicine: Managing Common Co-morbidities as One
  • 3.00 EBAC

Learning objectives

  • Describe the link between T2DM, CKD and ASCVD
  • State the importance of early and effective intervention in managing CVRM disease progression
  • List the guideline directed therapeutic targets in CVRM disease
  • Select appropriate patients for holistic CVRM management
  • Recall trial data for novel therapeutic agents that carry benefit for CVRM outcomes
  • Develop a holistic management strategy for CVRM disease with an evidence-based impact on clinical outcomes
See more
Managing Hypertension in CVD: How Low Can We Go?
  • 1.00 EBAC

Learning objectives

  • Describe the link between CVD and hypertension
  • Classify hypertension patients according to their cardiovascular risk
  • Recall recent guideline-directed and evidence-based strategies for managing very high CVD risk patients
  • Apply guideline-directed and evidence-based management strategies to a case study
  • Use expert guidance to adopt optimal multidisciplinary antihypertensive management strategies in patients with very high cardiovascular risk
See more
Advancements in Triglyceride-lowering Therapies
  • 1.00 EBAC

Learning objectives

  • Recall the primary and secondary outcomes from key triglyceride-lowering trials presented during ESC 2024
  • Discuss the current and future implication of trial results to clinical management and practice guidelines
See more